• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 22, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Accepted or rejected? Uncovering how fate of B cell is determined

Bioengineer by Bioengineer
April 26, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Osaka University

Osaka – When a pathogen evades or overcomes our innate immune defenses, the adaptive immune system kicks into action. There are two types of adaptive immune responses: cell-mediated immunity mediated by T cells and humoral immunity mediated by antibodies produced by B cells.

Affinity maturation of B cells in the germinal center (GC) is a process of evolution involving mutation of B cell receptors (BCRs) followed by selection through antigens and T cells. Consequently, an important GC function is to make the most effective antibodies possible, thereby providing efficient immune protection.

In GCs, B cells migrate between two zones, the light zone (LZ) and dark zone (DZ). Immune cells such as antigen-presenting follicular dendritic cells and T follicular helper (Tfh) cells reside in the LZ, and it is also here GC B cells expressing newly mutated BCRs capture antigen and internalize it for presentation to T cell. Subsequently, higher-affinity cells are directed to the plasma cell fate, whereas lower-affinity cells enter into the recycling GC cell pool. Plasma cells are fully differentiated B cells that produce a single type of antibody.

While it has been suggested that precursor cells (selected toward recycling GC or plasma cell fates) become committed already in the GCs, it is unclear how the plasma cell-prone GC cells develop. Clarifying these mechanisms will be valuable in developing effective vaccines to prevent viral infections such as influenza. A team of Osaka University-centered researchers set out to uncover this mystery, and reported its study in the journal, Immunity.

"In a mouse model, we were able to identify a small population of LZ GC B cells (Bcl6loCD69hi) with higher BCR affinity than other identified GC subpopulations. These Bcl6loCD69hi cells were preferentially committed to the plasma cell fate rather than to recycling in the GC," study first author Wataru Ise explains. "We also found that CD40 acted as a dose-dependent regulator of Bcl6loCD69hi cell formation."

The researchers also noted the expression of the proteins ICAM-1 and SLAM in Bcl6loCD69hi cells was higher than in Bcl6hiCD69hi cells, therefore affording more stable Tfh-GC B cell contacts. The results support the model whereby commitment to the plasma cell begins in the GC and suggest that stability of Tfh-GC B cell contacts is key for plasma cell-prone GC cell formation.

"Our data not only provided important information for vaccines development, but also open up new doors for further study," study corresponding author Tomohiro Kurosaki says. "The two important questions to address are: why Bcl6loCD69hi cells with higher c-Myc expression manifested less proliferation activity than Bcl6hiCD69hi cells, and why the Bcl6loCD69hi plasma cell-prone GC cells barely express Blimp-1, given the previous evidence that IL-21-mediated Stat3, together with IRF4, activates Blimp-1."

###

Osaka University was founded in 1931 as one of the seven imperial universities of Japan and now has expanded to one of Japan's leading comprehensive universities. The University has now embarked on open research revolution from a position as Japan's most innovative university and among the most innovative institutions in the world according to Reuters 2015 Top 100 Innovative Universities and the Nature Index Innovation 2017. The university's ability to innovate from the stage of fundamental research through the creation of useful technology with economic impact stems from its broad disciplinary spectrum.

Website: http://resou.osaka-u.ac.jp/en/top

Media Contact

Saori Obayashi
[email protected]
81-661-055-886
@osaka_univ_e

http://www.osaka-u.ac.jp/en

Original Source

http://resou.osaka-u.ac.jp/en/research/2018/20180418_1 http://dx.doi.org/10.1016/j.immuni.2018.03.027

Share12Tweet7Share2ShareShareShare1

Related Posts

blank

Just 37% of US States Mandate Medically Accurate Sexual Education in Schools

August 22, 2025
Cumulative Abdominal Obesity Raises Young Women’s Cancer Risk

Cumulative Abdominal Obesity Raises Young Women’s Cancer Risk

August 22, 2025

AI Uncovers Bufalin as Estrogen Receptor Degrader

August 22, 2025

Rethinking Peer Review: Ethics and Hidden Biases Unveiled

August 22, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

University of Ottawa Enters the Betavoltaic Battery Commercialization Arena

Calcium Testing in Poultry Unlocks Path to Enhanced Feed Efficiency

Just 37% of US States Mandate Medically Accurate Sexual Education in Schools

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.